Rapidscan Pharma Solutions
RapidScan is improving patient care surrounding the diagnosis of cardiac disease by reducing time and cost while increasing efficiency.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Rapidscan Pharma Solutions Information
Geographic Data
Address:
City: Palo Alto
State: California
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Rapidscan Pharma Solutions (RPS, Inc.) was formed in 2010 by leading members of the team that discovered and developed regadenoson, a new pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease. RPS, Inc. has licensed the rights to sell regadenoson in Europe and other select territories. Today, there are over 15M people in Europe with coronary artery disease, of which 1.5M patients undergo a myocardial perfusion imaging (MPI) procedure in the diagnosis of coronary artery disease (CAD).
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2010 | Series A | 1 | $2.4M |
Asset Management Ventures (AMV) Asset Management Ventures (AMV) |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
